COVID-19 Delays Expected Phase One Gains, Tanking US-China Trade in Q1
COVID-19 Delays Expected Phase One Gains, Tanking US-China Trade in Q1
May 13th, 2020
US-China trade plummeted in the first quarter of 2020 as global economic activity slowed dramatically due to COVID-19. Recently released US trade data show that goods imports from China dropped 28.4 percent year on year, while exports dropped 15.4 percent. US-China trade had already suffered in 2019 compared to years prior as a result of tariffs enacted by both countries.
China’s Finalized Cybersecurity Review Measures Illustrate Supply Chain Concerns
China’s Finalized Cybersecurity Review Measures Illustrate Supply Chain Concerns
May 13th, 2020
On April 27, the Cyberspace Administration of China (CAC), with 11 other ministries, released the final version of the Cybersecurity Review Measures (“measures”) which will build on a patchwork of documents implementing China’s Cybersecurity Law. The measures will govern the process for regulators to assess supply chain vulnerability of certain network systems that could impact China’s national security. The measures will go into effect on June 1, replacing the network security measures, a high-level document noted by members to have been largely unenforced.
How COVID-19 is Impacting the Congressional Landscape Around China
How COVID-19 is Impacting the Congressional Landscape Around China
May 13th, 2020
The spread of COVID-19 in the United States has underscored partisan divides on policy while simultaneously bringing to the surface some issues where long-term interests vis-à-vis China align. While some of the anti-China noise in Washington is political bluster, such as proposals to strip China of its sovereign immunity, other initiatives with bipartisan support could have broader implications for the direction of the US-China commercial relationship and supply chain resiliency.
Week in Review: Phase One Under Scrutiny, Interagency Looks at US Supply Chain Security, and Xinjiang Bill to Move
Week in Review: Phase One Under Scrutiny, Interagency Looks at US Supply Chain Security, and Xinjiang Bill to Move
May 8th, 2020
The top US and Chinese trade negotiators spoke on Thursday evening in a move to shield the agreement from increasing scrutiny and mounting anti-China sentiment due to the coronavirus. In addition to discussing the economic impact of the coronavirus, Ambassador Robert Lighthizer, Treasury Secretary Steven Mnuchin, and Chinese Vice Premier Liu He agreed that good progress is being made and that both sides fully expect to meet their obligations.
Week in Review: China Ensnared in Electoral Politics, Medical Supply Chains to be a Long-Term Debate, and Export Controls
Week in Review: China Ensnared in Electoral Politics, Medical Supply Chains to be a Long-Term Debate, and Export Controls
May 1st, 2020
Following the leak late last week of a National Republican Senatorial Committee memo advising candidates to aggressively attack China for COVID-19, the Trump administration and Congressional Republicans this week stepped up attacks targeting China’s role in the global pandemic. This includes reports that the administration is considering retaliatory actions to hold China accountable, such as by withholding debt payments, applying sanctions, levying new tariffs, blocking government investment in Chinese funds, or lifting China’s sovereign immunity to facilitate lawsuits seeking damages from China. New legislation proposed by Senators Tom Cotton (R-AR) and Josh Hawley (R-MO) calls for sanctions against Chinese officials for deliberately concealing information about the virus, and there have been additional calls for investigations of the origin of the virus, even as US intelligence officials reiterate that there is no evidence the virus is man-made.
Newly Empowered “Team Telecom” Gains Right to Review Existing FCC Licenses, Though Subject to New Constraints
Newly Empowered “Team Telecom” Gains Right to Review Existing FCC Licenses, Though Subject to New Constraints
April 29th, 2020
President Donald Trump’s April 4 executive order (EO) formalizing Team Telecom’s role in ICT reviews has brought new transparency to the licensing process while further entangling US national security and commercial interests. The interagency team, officially called the Committee for the Assessment of Foreign Participation in the United States Telecommunications Services Sector, is empowered to assist the Federal Communications Commission (FCC) in assessing whether certain foreign participation in the United States’s telecommunications sector poses a national security threat.
Proposed Rules and Existing Powers to Bar Imports With Content From Xinjiang
Proposed Rules and Existing Powers to Bar Imports With Content From Xinjiang
April 29th, 2020
Following cautionary reports from the US Congressional-Executive Commission on China (CECC) and the Australian Strategic Policy Institute (ASPI), US lawmakers last month proposed new limits and possible border blocks on imports from China that may have been produced with forced labor, such as garments made from cotton sourced in Xinjiang, China. This issue could pose significant disruptions to global retail supply chains as well as reputational concerns for brands and retailers.
Supply Chain Impacts of COVID-19
Supply Chain Impacts of COVID-19
April 29th, 2020
The COVID-19 pandemic exacerbates more than two years of trade-related stress on global supply chains. In the first quarter of this year, China’s economy contracted 6.8 percent compared with Q1 2019. This was the first reported contraction since Beijing began reporting quarterly GDP data in 1992. While many companies are optimistic that China’s economy will pick up in the second quarter, they harbor concerns China’s exports will continue to face challenges as the virus rattles major export markets like the United States and Europe. Virus-related disruptions are now resulting in increased scrutiny of companies’ future sourcing and investment strategies.
Exporting PPE from China FAQ
Exporting PPE from China FAQ
April 22nd, 2020
Earlier this month, the Chinese government tightened rules for exports of certain medical products used to combat COVID-19 in response to high-profile complaints about their quality. In light of these new requirements, exporters and importers of these goods can expect that the customs process will be delayed.
